GenMont Biotech Inc Cash Flow-to-Debt Ratio
GenMont Biotech Inc cash flow-to-debt ratio. GenMont Biotech Inc (3164) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of NT$15.46 Million could theoretically repay 0% of its total liabilities (NT$297.05 Million) in one year. Check 3164 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GenMont Biotech Inc (2005–2025)
Cash flow-to-debt ratio of GenMont Biotech Inc from 2005 to 2025. Historical debt coverage capacity for GenMont Biotech Inc across 21 annual periods. Check how aggressively does GenMont Biotech Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
GenMont Biotech Inc Cash Flow-to-Debt Ratio by Year (2005–2025)
GenMont Biotech Inc cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for GenMont Biotech Inc. For the full cash flow conversion analysis, see GenMont Biotech Inc (3164) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | NT$73.60 Million | NT$215.35 Million | ▼ -36.8% |
| 2024 | 0.54x | NT$123.95 Million | NT$229.06 Million | ▲ +219.1% |
| 2023 | 0.17x | NT$34.60 Million | NT$204.06 Million | ▼ -75.6% |
| 2022 | 0.69x | NT$137.95 Million | NT$198.59 Million | ▲ +8.0% |
| 2021 | 0.64x | NT$111.66 Million | NT$173.65 Million | ▼ -28.8% |
| 2020 | 0.90x | NT$118.27 Million | NT$130.95 Million | ▲ +49.1% |
| 2019 | 0.61x | NT$74.52 Million | NT$123.04 Million | ▲ +3.3% |
| 2018 | 0.59x | NT$56.03 Million | NT$95.60 Million | ▼ -2.2% |
| 2017 | 0.60x | NT$77.56 Million | NT$129.41 Million | ▲ +64.1% |
| 2016 | 0.37x | NT$45.34 Million | NT$124.14 Million | ▲ +1072.6% |
| 2015 | -0.04x | NT$-5.01 Million | NT$133.43 Million | ▲ +91.2% |
| 2014 | -0.43x | NT$-62.00 Million | NT$144.76 Million | ▼ -328.9% |
| 2013 | 0.19x | NT$100.37 Million | NT$536.49 Million | ▲ +549.6% |
| 2012 | -0.04x | NT$-23.58 Million | NT$566.61 Million | ▼ -161.3% |
| 2011 | 0.07x | NT$39.94 Million | NT$588.06 Million | ▼ -78.7% |
| 2010 | 0.32x | NT$200.03 Million | NT$627.66 Million | ▼ -74.0% |
| 2009 | 1.23x | NT$108.53 Million | NT$88.42 Million | ▼ -12.9% |
| 2008 | 1.41x | NT$100.62 Million | NT$71.36 Million | ▲ +53.0% |
| 2007 | 0.92x | NT$43.36 Million | NT$47.04 Million | ▲ +84.5% |
| 2006 | 0.50x | NT$29.56 Million | NT$59.18 Million | ▲ +22.8% |
| 2005 | 0.41x | NT$9.53 Million | NT$23.41 Million | — |